1 drug(s) with this reaction
5 total reports
Abdominal Distension has been reported as an adverse reaction across 1 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 5 adverse event reports mention abdominal distension in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with abdominal distension, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have abdominal distension listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal distension, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
1 drug(s) manufactured by Chattem Inc have abdominal distension listed in their FDA adverse event reports: TROLAMINE SALICYLATE.
There are a combined 5 reports of abdominal distension across 1 Chattem Inc drug(s) in the FDA adverse event database.